drug

PGN-EDODM1

1 story · latest Aug 6, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by PepGen Inc

Timeline

PepGen DSMB backs advance of PGN-EDODM1 to top dose in FREEDOM2-DM1

Aug 6Clinical readoutPepGen Inc PGN-EDODM1

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.